Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 2/20 | 0.40 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.38 |
| ▸ | CCNC | P24863 | 1/20 | 0.37 |
| ▸ | CDK8 | P49336 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.36 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL5671253 | 0.89 | MAPK1 (0.36) | PARP1ADRA1DCCNCCDK8GAA | |
| SCHEMBL2805436 | 0.88 | CCR2 (0.39) | GAAKMT2AALDH1A1CYP2D6MEN1 | |
| SCHEMBL27814642 | 0.85 | LMNA (0.43) | KMT2AALDH1A1CYP2D6HDAC8 | |
| SCHEMBL5673745 | 0.81 | BRD4 (0.43) | GAAALDH1A1 | |
| Trichloroacetic Acid SCHEMBL27834532 | 0.79 | LMNA (0.39) | KMT2AALDH1A1CYP2D6HDAC8 | |
| SCHEMBL6700044 | 0.79 | KDM4E (0.40) | ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL27834531 | 0.78 | LMNA (0.38) | CYP2D6HDAC8 | |
| SCHEMBL9640334 | 0.77 | CYP2D6 (0.35) | GAAKMT2AALDH1A1CYP2D6MEN1 | |
| SCHEMBL4726227 | 0.76 | SIGMAR1 (0.39) | KMT2AALDH1A1 | |
| SCHEMBL5680158 | 0.76 | TSHR (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110938667-A | Enzyme electrode, biosensor, preparation method and application thereof | 中国科学院天津工业生物技术研究所 | 2020-03-31 | — | — | CN | claimed |
| EP-2349328-A1 | METHODS FOR THE TREATMENT OF CANCER | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 2011-08-03 | — | — | EP | claimed |
| US-12331003-B2 | Photochemical separations and compositions | The Florida State University Research Foundation, Inc. (US) | 2025-06-17 | — | — | US | disclosed |
| US-12053765-B2 | Selective carbon dioxide reduction catalyzed by single metal sites on carbon nitride under visible light irradiation | UNIVERSITY OF NEW HAMPSHIRE (US) | 2024-08-06 | — | — | US | disclosed |
| WO-2024098042-A2 | GROWTH-BASED SELECTION PLATFORM FOR NONCANONICAL COFACTOR OXIDIZING ENZYMES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-05-10 | — | — | WO | disclosed |
| US-20230322857-A1 | RECOMBINANTLY ENGINEERED POLYPEPTIDES CAPABLE OF RECYCLING NONCANONICAL COFACTORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-10-12 | — | — | US | disclosed |
| US-20230278939-A1 | Photochemical Separations and Compositions | The Florida State University Research Foundation, Inc. | 2023-09-07 | — | — | US | disclosed |
| US-11591277-B2 | Photochemical separations and compositions | The Florida State University Research Foundation, Inc. (US) | 2023-02-28 | — | — | US | disclosed |
| EP-3655380-B1 | PHOTOCHEMICAL SEPARATIONS AND COMPOSITIONS | UNIV FLORIDA STATE RES FOUND INC (US) | 2021-12-22 | — | — | EP | disclosed |
| US-20200376475-A1 | SELECTIVE CARBON DIOXIDE REDUCTION CATALYZED BY SINGLE METAL SITES ON CARBON NITRIDE UNDER VISIBLE LIGHT IRRADIATION | UNIVERSITY OF NEW HAMPSHIRE (US) | 2020-12-03 | — | — | US | disclosed |
| US-20200172450-A1 | Photochemical Separations and Compositions | UNITED STATES DEPARTMENT OF ENERGY | 2020-06-04 | — | — | US | disclosed |
| US-20040235084-A1 | Novel agents for replacement of NAD+/NADH system in enzymatic reactions | ENERGY, UNITED STATES DEPARTMENT OF | 2004-11-25 | — | — | US | disclosed |
| EP-1468698-A2 | HUMAN QUINONE REDUCTASE 2 CONJUGATES FOR ADEPT AND GDEPT | ENZACTA R & D LIMITED (GB) | 2004-10-20 | — | — | EP | disclosed |
| US-6716596-B2 | biomimic cofactor; 3-substituted pyridium compounds; nicotinamides N-substituted with benzyl or polyoxyethylene glycol derivatives; bipyridyl rhodium hydride complex catalyst for reduction of the cofactor; polymer matrix; economical in large scale; biosensor or a chemical membrane bioreactor | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-04-06 | — | — | US | disclosed |
| EP-1373552-A2 | NOVEL AGENTS FOR REPLACEMENT OF NAD+/NADH SYSTEM IN ENZYMATIC RACTIONS | The Regents of the University of California (US) | 2004-01-02 | — | — | EP | disclosed |
| US-20030086933-A1 | Therapeutic systems | ENZACTA R & D LIMITED | 2003-05-08 | — | — | US | disclosed |
| US-20030022266-A1 | Novel agents for replacement of NAD+/NADH system in enzymatic reactions | ENERGY, U.S. DEPARTMENT OF | 2003-01-30 | — | — | US | disclosed |
| WO-2002072869-A2 | NOVEL AGENTS FOR REPLACEMENT OF NAD+/NADH SYSTEM IN ENZYMATIC RACTIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2002-09-19 | — | — | WO | disclosed |
| EP-0988059-A2 | HUMAN QUINONE REDUCTASE 2 CONJUGATES FOR ADEPT AND GDEPT | ENZACTA R & D LIMITED (GB) | 2000-03-29 | — | — | EP | disclosed |
| WO-1998057662-A2 | THERAPEUTIC SYSTEMS | ENZACTA R & D LIMITED (GB) | 1998-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230278939-A1 | Photochemical Separations and Compositions | APEX1, CYBA, MT-CO2 | PARP1 188/4885ADRA1D 4869/4885CCNC 501/4885 |
| US-20200172450-A1 | Photochemical Separations and Compositions | APEX1, CYBA, MT-CO2 | PARP1 188/4885ADRA1D 4869/4885CCNC 501/4885 |
| US-12331003-B2 | Photochemical separations and compositions | APEX1, CYBA, MT-CO2 | PARP1 188/4885ADRA1D 4869/4885CCNC 501/4885 |
| US-11591277-B2 | Photochemical separations and compositions | APEX1, CYBA, MT-CO2 | PARP1 188/4885ADRA1D 4869/4885CCNC 501/4885 |
| US-20030022266-A1 | Novel agents for replacement of NAD+/NADH system in enzymatic reactions | NQO1, NADK, ME2 | PARP1 406/4885ADRA1D 4265/4885CCNC 3525/4885 |
| US-20030086933-A1 | Therapeutic systems | NQO2, NQO1, NAPRT | PARP1 281/4885ADRA1D 4544/4885CCNC 3204/4885 |
| US-20040235084-A1 | Novel agents for replacement of NAD+/NADH system in enzymatic reactions | NQO1, NADK, ME2 | PARP1 406/4885ADRA1D 4265/4885CCNC 3525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.